Elinor is a Partner in the Corporate group and is part of the Corporate Technology and Life Sciences team.
Elinor specialises in venture capital, supporting high-growth companies in the technology sector. She advises on every stage of the life-cycle, from early-stage funding, through growth capital, international expansion, and to M&A. Elinor also advises institutional, corporate and individual investors on their investments into fast-growth companies. In addition, Elinor advises on buy and sell-side M&A transactions, restructurings and joint ventures, particularly within the technology sector.
Venture capital
Venture Capital
We have advised a syndicate of leading global life sciences investors including Access Biotechnology, Canaan Partners and SR One on their landmark US$140 million series A investment in Draig Therapeutics.
Press releaseWe have advised Mitel, a global leader in business communications, on its transaction to acquire Unify, the Unified Communications and Collaboration (UCC) and Communication and Collaboration Services businesses (CCS) of the Atos group.
Press releaseLong-standing client Nutmeg Saving and Investment Limited, one of the UK’s leading digital wealth managers, on its sale to JPMorgan Chase. The acquisition positions Nutmeg, with over 140,000 investors and £3.5 billion AUM, as an integral part of the bank’s international offering and complements the launch of Chase as a digital bank in the UK.
Press releaseThe shareholders of cyber security company MWR InfoSecurity Limited on its sale to F-Secure for GBP105m.
Advising on investments into multiple technology companies by leading venture capital funds.
Advising on venture capital fund raisings by tech companies, from early to later stage rounds.
作者 Oz Watson 以及 Giles Crown
作者 Dr. Paul Voigt, Lic. en Derecho, CIPP/E 以及 Stephanie Richter, LL.M. (Torino), CIPP/E
作者 Adeolu Faniran 以及 Louise Popple
作者 Louise Popple 以及 Moira Sy
作者 Louise Popple 以及 Ellie Harrison
作者 Sasun Sepoyan 以及 Otto Sleeking